中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
12期
28-29
,共2页
氨氯地平%阿托伐他汀%肥胖型高血压患者
氨氯地平%阿託伐他汀%肥胖型高血壓患者
안록지평%아탁벌타정%비반형고혈압환자
Amlodipine%Atorvastatin%Fueling patients with high blood pressure
目的：本文主要分析给予肥胖型高血压患者行氯地平联合阿托伐他汀治疗的临床效果。方法选取我院于2010年12月至2012年12月期间收治84例肥胖型高血压患者的临床资料，随机分为三组，即A组、B组、C组，每组28例，给予A组患者行单纯的氨氯地平治疗，给予B组患者行单纯的阿托伐他汀治疗，给予C组患者行氯地平联合阿托伐他汀治疗，对比各组患者的临床疗效。结果经过治疗，C组患者舒张压与收缩压的降压总有效率为96.42%，明显高于A组的78.57%与B组的71.42%；差异明显，有统计学意义（P＜0.05）；且各组患者的总胆固醇、三酰甘油与低密度脂蛋白胆固醇均比治疗前显著降低，差异明显，有统计学意义（P＜0.05）；高密度脂蛋白胆固醇均比治疗前显著提高，差异明显，有统计学意义（P＜0.05）。结论给予肥胖型高血压患者行氯地平联合阿托伐他汀治疗，降压降脂效果显著，值得临床推广。
目的：本文主要分析給予肥胖型高血壓患者行氯地平聯閤阿託伐他汀治療的臨床效果。方法選取我院于2010年12月至2012年12月期間收治84例肥胖型高血壓患者的臨床資料，隨機分為三組，即A組、B組、C組，每組28例，給予A組患者行單純的氨氯地平治療，給予B組患者行單純的阿託伐他汀治療，給予C組患者行氯地平聯閤阿託伐他汀治療，對比各組患者的臨床療效。結果經過治療，C組患者舒張壓與收縮壓的降壓總有效率為96.42%，明顯高于A組的78.57%與B組的71.42%；差異明顯，有統計學意義（P＜0.05）；且各組患者的總膽固醇、三酰甘油與低密度脂蛋白膽固醇均比治療前顯著降低，差異明顯，有統計學意義（P＜0.05）；高密度脂蛋白膽固醇均比治療前顯著提高，差異明顯，有統計學意義（P＜0.05）。結論給予肥胖型高血壓患者行氯地平聯閤阿託伐他汀治療，降壓降脂效果顯著，值得臨床推廣。
목적：본문주요분석급여비반형고혈압환자행록지평연합아탁벌타정치료적림상효과。방법선취아원우2010년12월지2012년12월기간수치84례비반형고혈압환자적림상자료，수궤분위삼조，즉A조、B조、C조，매조28례，급여A조환자행단순적안록지평치료，급여B조환자행단순적아탁벌타정치료，급여C조환자행록지평연합아탁벌타정치료，대비각조환자적림상료효。결과경과치료，C조환자서장압여수축압적강압총유효솔위96.42%，명현고우A조적78.57%여B조적71.42%；차이명현，유통계학의의（P＜0.05）；차각조환자적총담고순、삼선감유여저밀도지단백담고순균비치료전현저강저，차이명현，유통계학의의（P＜0.05）；고밀도지단백담고순균비치료전현저제고，차이명현，유통계학의의（P＜0.05）。결론급여비반형고혈압환자행록지평연합아탁벌타정치료，강압강지효과현저，치득림상추엄。
Objective This article mainly analyzes the chlorine horizon for fueling hypertension patients the clinical effect of combined therapy with atorvastatin. Methods Our hospital from December 2010 to December 2012, 84 patients treated during fueling the clinical data of patients with high blood pressure, and randomly divided into three groups, namely, group A and group B, group C, 28 cases in each group, and give the group A patients with pure amlodipine therapy, group B patients' line of pure atorvastatin treatment, to give the patients of group C chloride horizon joint atorvastatin treatment, comparison between groups of the patient's clinical curative effect. Results After treatment, the patients of group C diastolic and systolic blood pressure step-down the total effective rate was 96.42%, significantly higher than the 78.57%of 78.57%of the group A and group B;Clear difference was statistically significant (P<0.05);And groups of patients with total cholesterol, triglyceride and low density lipoprotein cholesterol than before treatment significantly reduced, clear difference was statistically significant(P<0.05);High density lipoprotein cholesterol were significantly enhanced compared to that before treatment, clear difference was statistically significant(P<0.05). Conclusion Fueling hypertension patients' chlorine horizon line with atorvastatin therapy, step-down lipid-lowering effect is significant, worthy of clinical promotion.
